Cardiovascular diseases still have a high prevalence and are the leading cause of death in most developed countries. However, cardiovascular medicine is also one of the disciplines with the most diagnostic and therapeutic advances, especially concerning medical devices, in the last two decades. Prominent examples are the subcutaneous ICD, leadless pacing, ventricular assist devices, use of artificial intelligence for ECG analysis and prediction of future events or CV outcome, and transcatheter valve repair).
We aim to elucidate further the impact of new cardiovascular technologies and their way into clinical practice. The focus is on active cardiac devices and the broadening of their therapeutic use, as well as the use of artificial intelligence to improve the diagnosis and treatment of CV diseases as there are many different effects recently developed devices may have on clinical practice. The same is valid for devices used for a new indication, which is also of high relevance. Original manuscripts, reviews (especially systematic meta-analyses), short communications, and case reports are of interest for publication.
We welcome the submission of manuscripts including, but not limited to, the following topics:
• Clinical studies using artificial intelligence to predict:
- The outcome of interventional or surgical valve repair/replacement (echo parameters, ECG parameters, laboratory findings)
- Sudden cardiac death (ECG, laboratory markers, echo, clinical features)
- Occurrence or progression of coronary artery disease (CAD) or peripheral arterial disease (PAD)
- Occurrence of thromboembolic events (stroke, pulmonary embolism, thrombosis)
• Use cardiovascular devices (stents, pacemakers, ICDs, occluders…) for new indications or in special subgroups.
• Manuscripts on remote monitoring of patients (e.g. loop recorders, ICDs…)
• Manuscripts on new software implemented in cardiovascular medicine (e.g. in the cath lab, in ECG analysis…)
Cardiovascular diseases still have a high prevalence and are the leading cause of death in most developed countries. However, cardiovascular medicine is also one of the disciplines with the most diagnostic and therapeutic advances, especially concerning medical devices, in the last two decades. Prominent examples are the subcutaneous ICD, leadless pacing, ventricular assist devices, use of artificial intelligence for ECG analysis and prediction of future events or CV outcome, and transcatheter valve repair).
We aim to elucidate further the impact of new cardiovascular technologies and their way into clinical practice. The focus is on active cardiac devices and the broadening of their therapeutic use, as well as the use of artificial intelligence to improve the diagnosis and treatment of CV diseases as there are many different effects recently developed devices may have on clinical practice. The same is valid for devices used for a new indication, which is also of high relevance. Original manuscripts, reviews (especially systematic meta-analyses), short communications, and case reports are of interest for publication.
We welcome the submission of manuscripts including, but not limited to, the following topics:
• Clinical studies using artificial intelligence to predict:
- The outcome of interventional or surgical valve repair/replacement (echo parameters, ECG parameters, laboratory findings)
- Sudden cardiac death (ECG, laboratory markers, echo, clinical features)
- Occurrence or progression of coronary artery disease (CAD) or peripheral arterial disease (PAD)
- Occurrence of thromboembolic events (stroke, pulmonary embolism, thrombosis)
• Use cardiovascular devices (stents, pacemakers, ICDs, occluders…) for new indications or in special subgroups.
• Manuscripts on remote monitoring of patients (e.g. loop recorders, ICDs…)
• Manuscripts on new software implemented in cardiovascular medicine (e.g. in the cath lab, in ECG analysis…)
